Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Moore

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|September 1, 1979
Synthesis of angiotensin II antagonists containing sarcosine in position 7G J Moore, E M Oudeman, D Ko, et al.
Magnetic Resonance in Medicine|January 1, 1991
Analysis of diabetic cataractogenesis using chemical-shift nuclear magnetic resonance microscopyH M Cheng, J B Aguayo, G J Moore, et al.
Journal of Applied Toxicology : JAT|January 9, 2003
Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide librariesJ Hayden, J Pires, S Roy, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 17, 1998
Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorderG J Moore, F P MacMaster, C Stewart, et al.
Molecular Pharmacology|June 1, 1993
Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypesM D Hollenberg, A A Laniyonu, M Saifeddine, et al.
Psychoneuroendocrinology|June 19, 2001
Prefrontal cortex as the site of estrogen's effect on cognitionP A Keenan, W H Ezzat, K Ginsburg, et al.
The Journal of Endocrinology|November 1, 1978
A high-molecular-weight substance in the supraoptic region of the rat hypothalamus which cross-reacts with a specific antiserum against arginine-vasopressin [proceedings]G J Moore, R W Swann, A W Fisher, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Design and pharmacology of peptide mimeticsG J Moore, J R Smith, B W Baylis, et al.
Journal of Child Neurology|September 29, 2001
Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imagingD R Rosenberg, A Amponsah, A Sullivan, et al.
Life Sciences|January 23, 1984
A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin IIM N Scanlon, J M Matsoukas, K J Franklin, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|September 1, 1979
Synthesis of angiotensin II antagonists containing sarcosine in position 7G J Moore, E M Oudeman, D Ko, et al.
Magnetic Resonance in Medicine|January 1, 1991
Analysis of diabetic cataractogenesis using chemical-shift nuclear magnetic resonance microscopyH M Cheng, J B Aguayo, G J Moore, et al.
Journal of Applied Toxicology : JAT|January 9, 2003
Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide librariesJ Hayden, J Pires, S Roy, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 17, 1998
Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorderG J Moore, F P MacMaster, C Stewart, et al.
Molecular Pharmacology|June 1, 1993
Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypesM D Hollenberg, A A Laniyonu, M Saifeddine, et al.
Psychoneuroendocrinology|June 19, 2001
Prefrontal cortex as the site of estrogen's effect on cognitionP A Keenan, W H Ezzat, K Ginsburg, et al.
The Journal of Endocrinology|November 1, 1978
A high-molecular-weight substance in the supraoptic region of the rat hypothalamus which cross-reacts with a specific antiserum against arginine-vasopressin [proceedings]G J Moore, R W Swann, A W Fisher, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Design and pharmacology of peptide mimeticsG J Moore, J R Smith, B W Baylis, et al.
Journal of Child Neurology|September 29, 2001
Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imagingD R Rosenberg, A Amponsah, A Sullivan, et al.
Life Sciences|January 23, 1984
A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin IIM N Scanlon, J M Matsoukas, K J Franklin, et al.
Pageof 17